Supradol is a medication that has a pronounced analgesic effect, moderate anti-inflammatory and antipyretic. The active substance is ketorolac tromethamine.
Supradol is prescribed for intense and moderate pain syndrome:
• for oncological pain
• neurological pain
• for injuries
• in the postoperative period
Supradol acts on COX1 and COX2, suppressing the biosynthesis of prostaglandidae - modulators of pain sensitivity, thermoregulation and inflammation. The medication does not affect opioid receptors, does not inhibit respiration, does not cause medication dependence, does not have a sedative and anxiolytic effect. After oral administration, the onset of analgesic action is noted after 60 minutes, the maximum effect is achieved after 1-2 hours and 2-3 hours.
When administered, Supradol is well absorbed in the gastrointestinal tract - the maximum plasma concentration (Cmax) (0.7-1.1 μg / ml) is achieved 40 minutes after a fasting dose of 10 mg. Foods rich in fats reduce the maximum concentration of the medication in the blood and delay its achievement by 1 hour. 99% of the medication binds to plasma proteins and with hypoalbuminemia, the amount of free substance in the blood increases. Bioavailability is 80-100%. The time to reach equilibrium concentration (Css) when administered orally is 24 hours when administered 4 times a day (higher than sub-therapeutic) and is after oral administration of 10 mg - 0.39-0.79 μg / ml. The volume of distribution is 0.15-0.33 l / kg. In patients with renal failure, the volume of distribution of the medication may increase by 2 times, and the volume of distribution of its R-enantiomer - by 20%. Penetrates into breast milk: when the mother takes 10 mg of Supradol Cmax in milk, it is reached 2 hours after the first dose and is 7.3 ng / ml, 2 hours after the second dose of Supradol (when using the medication 4 times a day) - 7.9 ng / ml.
More than 50% of the administered dose is metabolized in the liver with the formation of pharmacologically inactive metabolites. The main metabolites are glucuronides. It excreted by the kidneys and p-hydroxyketorolac. It is excreted by 91% by the kidneys and 6% through the intestines. Half-life (T1 / 2) in patients with normal renal function is on average 5.3 hours. T1 / 2 increases in elderly patients and shortens in young patients. Liver function has no effect on T1 / 2. In patients with impaired renal function with a creatinine concentration in plasma of 19-50 mg / l (168-442 mmol / l). T1 / 2 - 10.3-10.8 hours, with more severe renal failure - more than 13.6 hours.It is not excreted by hemodialysis.
Supradol is not used to treat chronic pain. The medication has contraindications:
• hypersensitivity to ketorolac or other non-steroidal anti-inflammatory medications (NSAIDs);
• intolerance to acetylsalicylic acid;
• bronchial asthma, recurrent polyps of the nose and sinuses;
• any allergic reactions caused by a history of NSAIDs;
• ulcer during exacerbation;
• any inflammation of the digestive tract;
• renal or liver failure;
• risk of bleeding;
• the period after coronary artery bypass grafting;
• ischemic, hemorrhagic stroke;
• lactose intolerance, lactase deficiency, glucose-galactose malabsorption;
• children and adolescents under 16 years of age (effectiveness and safety have not been established);
• lactation period.
Dosage and administration
A single dose of Supradol is 10 mg. Depending on the intensity of the pain, up to 4 medications per day are allowed. The maximum daily dose is 40 mg. You should not take Supradol for more than 5 days.
In case of an overdose, the following symptoms may be observed: abdominal pain, nausea, vomiting, the appearance of peptic ulcers of the stomach or erosive gastritis, impaired renal function, metabolic acidosis.
Treatment is carried out by gastric lavage, the introduction of adsorbents (activated charcoal) and symptomatic therapy (maintaining vital functions in the body). Not sufficiently excreted by dialysis.
Often - more than 3%, less often - 1-3%, rarely - less than 1%.
From the digestive system: gastralgia, diarrhea; less often - stomatitis, flatulence, constipation, vomiting, a feeling of fullness of the stomach; rarely - nausea, erosive and ulcerative lesions of the gastrointestinal tract (including with perforation and / or bleeding - abdominal pain, spasm or burning in the epigastric region, blood in the stool or melena, vomiting with blood, nausea, heartburn, etc.) , cholestatic jaundice, hepatitis, hepatomegaly, acute pancreatitis.
From the urinary system: rarely - acute renal failure, lower back pain with or without hematuria and / or azotemia, hemolytic uremic syndrome (hemolytic anemia, renal failure, thrombocytopenia, purpura), frequent urination, increased or decreased urine volume, nephritis, edema renal origin.
From the sensory organs: rarely - hearing loss, tinnitus, visual impairment (including blurred visual perception).From the respiratory system: rarely - bronchospasm or dyspnea, rhinitis, pulmonary edema, laryngeal edema (shortness of breath, shortness of breath).
From the side of the central nervous system: often - headache, dizziness, drowsiness, rarely - aseptic meningitis (fever, severe headache, cramps, stiff muscles of the neck and / or back), hyperactivity (mood changes, anxiety), hallucinations, depression, psychosis.
From the cardiovascular system: increased blood pressure, pulmonary edema, loss of consciousness.
From the hemopoietic organs: anemia, leukopenia, eosinophilia.
On the part of the hemostatic system: rarely - bleeding from a postoperative wound, nosebleeds, rectal bleeding.
On the part of the skin: less often - a skin rash (including maculopapullous rash), purpura, rarely - exfoliative dermatitis (fever with or without chills, flushing, tightening or peeling of the skin, swelling and / or tenderness of the tonsils), urticaria, malignant exudative (Stevens-Johnson syndrome), toxic epidermal necrolysis (Lyell's syndrome).
Local reactions: less often - burning or pain at the injection site.
Allergic reactions: rare - anaphylaxis or anaphylactoid reactions (discoloration of the face, skin rash, urticaria, itchy skin, tachypnea or dyspnea, edema of the eyelids, periorbital edema, shortness of breath, shortness of breath, heaviness in the chest, wheezing).
Other: often - edema (face, legs, ankles, fingers, feet, weight gain); less often - increased sweating, rare - swelling of the tongue, fever.
On the off chance that its not greatly inconvenience guide your specialist before taking any arrangement. Supradol 10mg 30 Tabs Generic Name: Ketorolac Trometamol Non-sedative torment soothing. SUPRADOL ® tablets, sublingual tablets and mixture course of action is demonstrated for the treatment of extraordinary torment in the short term. SUPRADOL ® Gel, topically associated moderating agony soothing for the treatment of muscle misery, joint and post-traumatic. It is convincing in the treatment of fragile tissue wounds, for instance, sprains, strains, bursitis, tendinitis, epicondylitis, synovitis and osteoarthritis joints surface (finger, knee, lower l
Expected delivery time
10-15 business days ( or even faster depending on your location)
- Credit Card
- Money Transfer (WESTERN UNION)
- Domestic Bank Wire ( Special discount with this payment method)